A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 11, 2009, Pages 1254-1262

  Ortonne, Jp ^a   Arellano, I ^b   Berneburg, M ^c   Cestari, T ^d   Chan, H ^e   Grimes, P ^f   Hexsel, D ^g   Im, S ^h   Lim, J ⁱ   Lui, H ^j   Pandya, A ^k   Picardo, M ^l   Rendon, M ^m   Taylor, S ⁿ   Van Der Veen, Jpw ^o   Westerhof, W ^o  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^e UNIVERSITY OF HONG KONG   (Hong Kong)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PASSO FUNDO   (Brazil)

^h Kangnam Wootaeha Skin Clinic   (South Korea)

ⁱ Skin and Laser Clinic   (Singapore)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k UNIVERSITY OF TEXAS AT DALLAS   (United States)

^l SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^m Dermatology and Aesthetic Center   (United States)

ⁿ ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^o UNIVERSITY OF AMSTERDAM   (Netherlands)

more..

Author keywords

Global; Hormonal; Melasma; Pregnancy; Sun exposure; Women's health

Indexed keywords

SUNSCREEN;

ADULT; AGED; ARTICLE; CHLOASMA; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIPLE PREGNANCY; PREGNANCY; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN COLOR; ULTRAVIOLET RADIATION;

ADULT; FEMALE; HORMONES; HUMANS; MELANOSIS; PREGNANCY; QUESTIONNAIRES; ULTRAVIOLET RAYS;

EID: 70349960051     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03295.x     Document Type: Article

References (30)

1. Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol 1999 455 : 491 499.
2. Grimes P, Kelly AP, Torok H et al. Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis 2006, 77, 177 184.
3. Grimes PE, Yamada N, Bhawan J. Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 2005 27 : 96 101.
4. Balkrishnan R, McMichael AJ, Camacho FT et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 2003 149 : 572 577.
5. Pawaskar M, Parikh P, Markowski T et al. Melasma and its impact on health-related quality of life in Hispanic Women. J Dermatolog Treatment 2007 18 : 5 9.
6. Cestari T, Hexsel D, Viegas M et al. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol 2007 156 : 13 20.
7. Rendon M. Utilizing combination therapy to optimize melasma outcomes. J Drugs Dermatol 2004 3 : S27 S34.
8. Wong RC, Ellis CN. Physiologic changes in pregnancy. J Am Acad Dermatol 1984 10 : 929 940.
9. Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 2006 45 : 285 288.
10. Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy. Int J Dermatol 1998 37 : 429 431.
11. Iraji F. Studying skin changes in 235 pregnant women. Isfahan Med Univ J 1998 54 : 13 17.
12. Estev E. Physiological cutaneous sign in normal pregnancy. Ann Dermatol 1994 21 : 227 231.
13. Grimes P. Incidence and Psychosocial Implications of Melasma. Poster presented at the American Academy of Dermatology, Summer Meeting, New York, 2003.
14. Taylor SC. Epidemiology of skin diseases in ethnic populations. Dermatol Clin 2003 21 : 601 607.
15. Arenas R. Melasma. In : Arenas R, ed. Dermatologia: Atlas, Diagnostico Y Tratamiento. Interamericana-McGraw-Hill, Mexico City, Mexico, 1996, 96.
16. American Academy of Dermatology. Dermatologists Dis-'Patch' Dark Side of Melasma. http://www.aad.org/media/background/news/skinconditions-2004-02-06- derm.html. Last accessed 13 October 2008.
17. Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatol Clin 2000 18 : 91 98.
18. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995 131 : 1453 1457.
19. Resnik S. Melasma induced by oral contraceptive drugs. JAMA 1967 199 : 95.
20. Hexsel D, Dal'Forno T, Zechmeister D, Lima M. A Review of Clinical Data from 100 Brazilian Patients Affected by Melasma. Poster presented at AAD, Chicago, 2005
21. Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg 1999 25 : 282 284.
22. Dogra A, Gupta S, Gupta S. Comparative efficacy of 20% trichloroacetic acid and 50% glycolic acid peels in treatment of recalcitrant melasma. J Pakistan Associat Dermatologists 2006 16 : 79 85.
23. Goh CL, Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J 1999 40 : 455 458.
24. Benchikhi H, Razoki H, Lakhdar H. Sunscreens: use in pregnant women in Casablanca. Ann Dermatol Venereol 2002 129 (Part 1 387 390.
25. Maeda K, Naganuma M, Fukuda M et al. Effect of pituitary and ovarian hormones on human melanocytes in vitro. Pigment Cell Res 1996 9 : 204 212.
26. Pathak MA, Fitzpatrick TB, Kraus EW. Usefulness of retinoic acid in the treatment of melasma. J Am Acad Dermatol 1986 15 : 894 899.
27. Sanchez NP, Pathak MA, Sato S et al. Melasma: a clinical, light microscopic, ultrastructural, and immunoflurescence study. J Am Acad Dermatol 1981 4 : 698 710.
28. Kang WH, Yoon KH, Lee ES et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002 146 : 228 237.
29. Vasquez M, Sanchez JL. The efficacy of a broad-spectrum sunscreen in the treatment of melasma. Cutis 1983 32 : 95 96.
30. Gupta AK, Gover MD, Nouri K et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 2006 55 : 1048 1065.